Hoeft, K.* ; Koch, L.* ; Ziegler, S.* ; Zhang, L.* ; Luetke, S.* ; Tanzer, M.C.* ; Mohanta, D.* ; Schumacher, D.* ; Schreibing, F.* ; Long, Q.* ; Kim, H.* ; Klinkhammer, B.M.* ; Schikarski, C.* ; Maryam, S.* ; Baens, M.* ; Hermann, J.* ; Krieg, S.* ; Peisker, F.* ; De Laporte, L.* ; Schaefer, G.J.L.* ; Menzel, S.* ; Jankowski, J.* ; Humphreys, B.D.* ; Wahida, A. ; Schneider, R.K.* ; Versele, M.* ; Boor, P.* ; Mann, M.* ; Sengle, G.* ; Hayat, S.* ; Kramann, R.*
ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts.
J. Clin. Invest. 134:e170246 (2024)
Fibrosis represents the uncontrolled replacement of parenchymal tissue with extracellular matrix (ECM) produced by myofibroblasts. While genetic fate-tracing and single-cell RNA-Seq technologies have helped elucidate fibroblast heterogeneity and ontogeny beyond fibroblast to myofibroblast differentiation, newly identified fibroblast populations remain ill defined, with respect to both the molecular cues driving their differentiation and their subsequent role in fibrosis. Using an unbiased approach, we identified the metalloprotease ADAMTS12 as a fibroblast-specific gene that is strongly upregulated during active fibrogenesis in humans and mice. Functional in vivo KO studies in mice confirmed that Adamts12 was critical during fibrogenesis in both heart and kidney. Mechanistically, using a combination of spatial transcriptomics and expression of catalytically active or inactive ADAMTS12, we demonstrated that the active protease of ADAMTS12 shaped ECM composition and cleaved hemicentin 1 (HMCN1) to enable the activation and migration of a distinct injury-responsive fibroblast subset defined by aberrant high JAK/STAT signaling.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Cardiology ; Fibrosis ; Nephrology; Pathway Activation; Cells; Contributes; Growth; Image
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
0021-9738
e-ISSN
1558-8238
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 134,
Issue: 18,
Pages: ,
Article Number: e170246
Supplement: ,
Series
Publisher
American Society of Clinical Investigation
Publishing Place
2015 Manchester Rd, Ann Arbor, Mi 48104 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-506900-001
Grants
Max Planck Society for the Advancement of Science
German Society for Cardiology Otto-Hess MD
German Research Foundation (DFG)
Europe-an Research Council
Else Kroener Fresenius Foundation (EKFS)
BMBF
BMBF consortia CureFib
DFG
European Research Council
Federal Ministry of Education and Research (BMBF)
German Society of Internal Medicine Peter Scriba
Copyright
Erfassungsdatum
2024-10-28